1.
Use of acetazolamide in the treatment of patients with refractory congestive heart failure
by Núñez, Julio
Cardiovascular therapeutics, 2018-12, Vol.36 (6), p.e12465-n/a
2.
AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice
by Zhang, Ping
Hypertension (Dallas, Tex. 1979), 2008-11, Vol.52 (5), p.918-924
3.
Corrigendum to “Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)” ( Am Heart J....
by Dokainish, Hisham, MD
The American heart journal, 2015, Vol.172, p.201-201
4.
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study
by Moreau, Philippe
The lancet oncology, 2018-07, Vol.19 (7), p.953-964
5.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 stu...
by Kim, Sung-Bae
The lancet oncology, 2020-04, Vol.21 (4), p.519-530
6.
Left ventricular pacing improves haemodynamic variables in patients with heart failure with a normal QRS duration
by Turner, M S
Heart (British Cardiac Society), 2004-05, Vol.90 (5), p.502-505
7.
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
by Salles, Gilles
The lancet oncology, 2020-07, Vol.21 (7), p.978-988
8.
Inspiratory Muscle Weakness in Diastolic Dysfunction
by Lavietes, Marc H
Chest, 2004-09, Vol.126 (3), p.838-844
9.
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
by Avina-Zubieta, Juan Antonio
Annals of the rheumatic diseases, 2012-09, Vol.71 (9), p.1524-1529
10.
Chronic obstructive pulmonary disease
by Rabe, Klaus F, Prof
The Lancet (British edition), 2017, Vol.389 (10082), p.1931-1940
11.
Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
by Ohkuma, Toshiaki
Diabetologia, 2019-07-18, Vol.62 (9), p.1550-1560
12.
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
by Taylor, Doris A
Nature medicine, 2008-02, Vol.14 (2), p.213-221
13.
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
by Böhm, Michael, Prof
The Lancet (British edition), 2017, Vol.389 (10085), p.2226-2237
14.
Cultural diversity In heart failure management: Findings from the Discover Study (Part 2)
by Davidson, Patricia M
Contemporary nurse : a journal for the Australian nursing profession, 2007-05-01, Vol.25 (1-2), p.50-62
15.
Sex differences in cardiometabolic disorders
by Gerdts, Eva
Nature medicine, 2019-11, Vol.25 (11), p.1657-1666
16.
Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial
by Yao, Xiaoxi
Nature medicine, 2021-05, Vol.27 (5), p.815-819
17.
Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy
by Moretti, A
Nature medicine, 2020-02, Vol.26 (2), p.207-214
18.
Impaired Myocardial Functional Reserve in Hypertension and Diabetes Mellitus Without Coronary Artery Disease: Searching for the Possible Link With Congestive Heart Failure in the M...
by Govind, Satish
American journal of hypertension, 2006, Vol.19 (8), p.851-857
19.
Hypertrophic obstructive cardiomyopathy
by Veselka, Josef, Prof
The Lancet (British edition), 2016, Vol.389 (10075), p.1253-1267
20.
Effect of intensive glucose lowering treatment on all cause mortality cardiovascular death and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trial...
by Boussageon, R.
British medical journal, 2011, Vol.343, p.1-12
